UA99678C2 - COMBINATION DOSAGE FORM CONTAINING A TAMSULOSIN AND TESTOSTERONE-5a-REDUCTASE INHIBITOR - Google Patents

COMBINATION DOSAGE FORM CONTAINING A TAMSULOSIN AND TESTOSTERONE-5a-REDUCTASE INHIBITOR

Info

Publication number
UA99678C2
UA99678C2 UAA201107271A UAA201107271A UA99678C2 UA 99678 C2 UA99678 C2 UA 99678C2 UA A201107271 A UAA201107271 A UA A201107271A UA A201107271 A UAA201107271 A UA A201107271A UA 99678 C2 UA99678 C2 UA 99678C2
Authority
UA
Ukraine
Prior art keywords
pellets
tamsulosin
population
dosage form
form containing
Prior art date
Application number
UAA201107271A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
ден Хевел Денні Йохан Марейн ван
Йоханнес Вільгельмус Мауріс Веєрс
Дірк Памперін
Original Assignee
Сінтон Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сінтон Б.В. filed Critical Сінтон Б.В.
Priority to UAA201107271A priority Critical patent/UA99678C2/en
Publication of UA99678C2 publication Critical patent/UA99678C2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a population of tamsulosin-comprising pellets for oral administration of a combination dosage form containing physically separated a tamsulosin dose in the form of the population of the tamsulosin comprising pellets and at least one other dose of a pharmaceutically active substance, said pellets comprising tamsulosin hydrochloride uniformly dispersed in a carrier matrix, wherein (i) said pellets in the population have a size of less than about 1.4 mm and, advantageously, at least 90 % of the pellets have a size of larger than 0.30 mm; and (ii) an average content of tamsulosin hydrochloride in the population of pellets is between about 0.15-3.00 weight percent, calculated on a dry pellet basis, to a process of making such population of pellets, and to their use.
UAA201107271A 2008-12-09 2008-12-09 COMBINATION DOSAGE FORM CONTAINING A TAMSULOSIN AND TESTOSTERONE-5a-REDUCTASE INHIBITOR UA99678C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201107271A UA99678C2 (en) 2008-12-09 2008-12-09 COMBINATION DOSAGE FORM CONTAINING A TAMSULOSIN AND TESTOSTERONE-5a-REDUCTASE INHIBITOR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201107271A UA99678C2 (en) 2008-12-09 2008-12-09 COMBINATION DOSAGE FORM CONTAINING A TAMSULOSIN AND TESTOSTERONE-5a-REDUCTASE INHIBITOR

Publications (1)

Publication Number Publication Date
UA99678C2 true UA99678C2 (en) 2012-09-10

Family

ID=50850210

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201107271A UA99678C2 (en) 2008-12-09 2008-12-09 COMBINATION DOSAGE FORM CONTAINING A TAMSULOSIN AND TESTOSTERONE-5a-REDUCTASE INHIBITOR

Country Status (1)

Country Link
UA (1) UA99678C2 (en)

Similar Documents

Publication Publication Date Title
RS20070511A (en) Modified release pharmaceutical compositions and processes thereof
EA201400972A1 (en) MEDICAL FORMS OF IMMEDIATE DELIVERY WITH PROTECTION AGAINST UNAUTHORIZED APPLICATION
NI201300054A (en) ENCLOSED CONTROLLED RELEASE DOSE FORMS RESISTANT TO IMPROPER HANDLING
NZ594022A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
TW200635618A (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
IL174830A0 (en) Pellets containing venlafaxine hydrochloride, pharmaceutical compositions comprising them and processes for their preparation
EA201170784A1 (en) TAMSULUS GRANULES FOR FIXED COMBINATION
EP2477608A4 (en) Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
MX2007006212A (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form.
PE20061017A1 (en) PHARMACEUTICAL FORMULATION BY DIRECT COMPRESSION OF A DIPEPTIDIL-PEPTIDASE IV INHIBITOR AND PROCESS
CR11724A (en) AGENT TO TREAT DISEASES
HK1115070A1 (en) Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
BRPI0403935B8 (en) azithromycin dosage forms with reduced side effects
MX2010010026A (en) Agent for treating disease.
MX2010008138A (en) Pharmaceutical dosage form.
AR038899A1 (en) A MEDICINAL PRODUCT FOR ANIMALS
MY147641A (en) Fast release paracetamol tablets
MX363495B (en) Process of manufacturing a lyophilized fast dissolving, muti-phasic dosage form.
MX2008002512A (en) Drug compositions containing controlled release hypromellose matrices.
TW200624127A (en) New modified release pellet formulations for proton pump inhibitors
NZ596064A (en) Fixed dose drug combination formulations
PT1411921E (en) Pharmaceutical compositions containing terbinafine and use thereof
MX2010004962A (en) Homogeneous and storage-stable mixtures of different active plant protection agent granule particles.
MX2009006699A (en) Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients.
TW200621312A (en) Oral solid dosage forms containing a low dose of estradiol